Results 201 to 210 of about 157,517 (252)
Conformational dynamics and binding free energy analyses unveil a stable flavonoid inhibitor of dengue virus NS5 polymerase. [PDF]
Sci RepAlsaady IM +5 more
europepmc +1 more source
The dengue virus NS1 protein alters <i>Aedes aegypti</i> midgut permeability and favors virus dissemination. [PDF]
mBioQuezada-Ruiz E +11 more
europepmc +1 more source
Epidemiology and severity risk factors of dengue virus infection during the 2023-2024 outbreak in Colombia. [PDF]
PLoS Negl Trop DisTorres-Hernández D +10 more
europepmc +1 more source
Prevalence of dengue virus among febrile patients in urban setting of Bamako, Mali. [PDF]
IJID RegCissoko Y +18 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Pediatric Infectious Disease Journal, 2003
Dengue fever is an acute self-limited mosquito-borne viral infection causing fever myalgia arthralgia headache rash and leukopenia. Thrombocytopenia and occasionally hemorrhage may develop in classic dengue fever but these are not prominent features.
Aric, Gregson, Robert, Edelman
openaire +2 more sources
Dengue fever is an acute self-limited mosquito-borne viral infection causing fever myalgia arthralgia headache rash and leukopenia. Thrombocytopenia and occasionally hemorrhage may develop in classic dengue fever but these are not prominent features.
Aric, Gregson, Robert, Edelman
openaire +2 more sources
Current Opinion in Pediatrics, 2002
Dengue is the most important arthropod-borne viral disease of public health significance. Its geographic distribution includes more than 100 countries worldwide, where more than 2.5 billion people are at risk for dengue infections. Most people will have asymptomatic infections, but the disease manifestations range from an influenza-like disease known ...
Benedito Antônio Lopes, da Fonseca +1 more
openaire +2 more sources
Dengue is the most important arthropod-borne viral disease of public health significance. Its geographic distribution includes more than 100 countries worldwide, where more than 2.5 billion people are at risk for dengue infections. Most people will have asymptomatic infections, but the disease manifestations range from an influenza-like disease known ...
Benedito Antônio Lopes, da Fonseca +1 more
openaire +2 more sources
Dengue Virus Vaccine Development
2014Dengue virus (DENV) is a significant cause of morbidity and mortality in tropical and subtropical regions, causing hundreds of millions of infections each year. Infections range from asymptomatic to a self-limited febrile illness, dengue fever (DF), to the life-threatening dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS).
Lauren E, Yauch, Sujan, Shresta
openaire +2 more sources